Qualitative and quantitative scintigraphy in sialorrhea before and after botulinum toxin injection
- 28 January 2019
- journal article
- research article
- Published by Wiley in The Laryngoscope
- Vol. 129 (11) , 2521-2526
Abstract
Objectives/Hypothesis: Sialorrhea is excessive saliva production and its usual escape of from the oral cavity. The use of botulinum toxin has been preconized, but its effectiveness until now has been unreliably measured. Our objective was to qualitatively and quantitatively determine the effectiveness of botulinum toxin injection in the reduction of saliva production by the parotid gland.Study Design: Outcomes research.Methods: Patients with moderate‐to‐critical sialorrhea had one of the parotid glands injected with 50 U of botulinum toxin, leaving the other as the control. Fifteen days after the toxin injection, they underwent scintigraphic analyses with intravenous injection of 10 mCi (37 MBq) of Tc‐99 m (sodium pertechnetate). After this, the noninjected gland was treated for therapeutic complementation.Results: The glands injected with botulinum toxin showed uptake reduction in 100% of patients. The uptake reduction in counts per second varied from 8% to 36%. The Wilcoxon paired test comparing the control glands with those injected showed a significant difference for the action of botulinum toxin (P = .0039).Conclusions: The scintigraphic study of parotid glands shows that botulinum toxin is effective in reducing sodium pertechnetate uptake.Level of Evidence: 2c Laryngoscope, 129:2521–2526, 2019Keywords
This publication has 22 references indexed in Scilit:
- Sialorrhea: Anatomy, Pathophysiology and Treatment with Emphasis on the Role of Botulinum ToxinsToxins, 2013
- Botulinum Toxin for the Treatment of SialorrheaOtolaryngology–Head and Neck Surgery, 2012
- Treatment of sialorrhea in children with Cerebral Palsy: A double-blind placebo controlled trialClinical Neurology and Neurosurgery, 2009
- Scintigraphic analysis of the parotid glands in patients with sialorrhea and Parkinson's diseaseParkinsonism & Related Disorders, 2008
- Sialorrhea in Parkinson's disease: A reviewMovement Disorders, 2007
- Botulinum toxin A for drooling in Parkinson's disease: A pilot study to compare submandibular to parotid gland injectionsParkinsonism & Related Disorders, 2007
- Parotid and submandibular botulinum toxin A injections for sialorrhoea in children with cerebral palsyDevelopmental Medicine & Child Neurology, 2006
- Effect of Botulinum Toxin in the Treatment of Drooling: A Controlled Clinical TrialPediatrics, 2004
- Injections of botulinum toxin A into the salivary glands improve sialorrhoea in amyotrophic lateral sclerosisJournal of Neurology, Neurosurgery & Psychiatry, 2000
- Appliance therapy for chronic drooling in a patient with mental retardationSpecial Care in Dentistry, 1994